Free Trial

Iterum Therapeutics (ITRM) SEC Filings & 10K Form

Iterum Therapeutics logo
$0.91 -0.01 (-1.09%)
As of 09:48 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Iterum Therapeutics SEC Filings

DateFilerForm TypeView
05/19/2025
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
6:30 AM
Iterum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
8:11 PM
Iterum Therapeutics (Filer)
Form 424B5
04/29/2025
8:16 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
7:00 AM
Iterum Therapeutics (Issuer)
Whalen Joseph John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2025
7:35 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
11:15 PM
Iterum Therapeutics (Filer)
Form EFFECT
02/14/2025
4:36 PM
ARMISTICE CAPITAL, LLC (Filed by)
Iterum Therapeutics (Subject)
Form SCHEDULE 13G/A
02/07/2025
3:33 PM
Iterum Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/07/2025
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
6:30 AM
Iterum Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/23/2025
5:30 PM
HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
5:30 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
6:04 AM
Iterum Therapeutics (Filer)
Form 424B5
11/21/2024
8:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:54 PM
Iterum Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
6:30 AM
Iterum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2024
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2024
4:10 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
5:24 AM
Iterum Therapeutics (Filer)
Form 424B5
10/28/2024
5:06 AM
Iterum Therapeutics (Filer)
Form 424B5
10/25/2024
10:20 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
7:00 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
8:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2024
4:20 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:15 PM
Iterum Therapeutics (Filer)
Form DEFA14A
09/30/2024
6:30 AM
Iterum Therapeutics (Filer)
Form DEFA14A
09/24/2024
7:59 AM
Iterum Therapeutics (Filer)
Form DEFA14A
09/24/2024
8:01 AM
Iterum Therapeutics (Filer)
Form DEFA14A
09/23/2024
5:30 AM
Iterum Therapeutics (Filer)
Form DEFA14A
09/11/2024
3:50 PM
Iterum Therapeutics (Filer)
Form DEFA14A
09/09/2024
5:15 AM
Iterum Therapeutics (Filer)
Form DEFA14A
08/14/2024
6:30 AM
Iterum Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
6:15 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
11:15 PM
Iterum Therapeutics (Filer)
Form EFFECT
08/12/2024
8:00 AM
HUNT RONALD (Reporting)
Iterum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:00 AM
Fishman Corey N. (Reporting)
Iterum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
8:00 AM
Dunne Michael W. (Reporting)
Iterum Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
4:28 PM
Iterum Therapeutics (Filer)
Form POS AM
08/06/2024
4:25 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Is President Trump Lying To You With This? (Ad)

President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to protect your 401(k), IRA, or pension from market chaos and currency collapse? The 2025 Wealth Protection Guide reveals a legal IRS strategy that may let you keep more of your retirement—regardless of what happens next. Trump’s warning was real. So is this opportunity.

Protect your IRA—Trump’s warning was real
08/02/2024
3:30 PM
Iterum Therapeutics (Filer)
Form PRE 14A
07/22/2024
7:30 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2024
11:15 PM
Iterum Therapeutics (Filer)
Form EFFECT
07/19/2024
4:05 PM
Iterum Therapeutics (Filer)
Form 424B3
07/17/2024
3:21 PM
Iterum Therapeutics (Filer)
Form S-1/A
06/26/2024
4:24 PM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2024
4:27 PM
Iterum Therapeutics (Filer)
Form S-1/A
06/21/2024
7:30 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:11 PM
Iterum Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/31/2024
7:30 AM
Iterum Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ITRM) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners